Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$209.01 - $232.56 $222,177 - $247,211
-1,063 Reduced 63.69%
606 $132,000
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $329,944 - $379,347
1,669 New
1,669 $379,000
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $300,728 - $342,447
-1,419 Reduced 88.91%
177 $42,000
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $591,109 - $714,446
-2,771 Reduced 63.45%
1,596 $366,000
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $776,580 - $949,073
3,812 Added 686.85%
4,367 $1.03 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $113,055 - $144,728
552 Added 18400.0%
555 $114,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $4.04 Million - $4.63 Million
-15,532 Reduced 99.98%
3 $1,000
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $15.1 Million - $17.5 Million
-55,610 Reduced 78.16%
15,535 $4.88 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $5.86 Million - $6.57 Million
21,305 Added 42.75%
71,145 $20 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $9.25 Million - $10.2 Million
36,724 Added 279.99%
49,840 $13.7 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $2.08 Million - $2.39 Million
11,137 Added 562.76%
13,116 $2.67 Million
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $2.82 Million - $3.4 Million
-16,887 Reduced 89.51%
1,979 $372,000
Q4 2019

Feb 13, 2020

BUY
$163.48 - $173.61 $2.77 Million - $2.94 Million
16,918 Added 868.48%
18,866 $3.19 Million
Q3 2019

Nov 08, 2019

SELL
$159.77 - $178.1 $1.95 Million - $2.18 Million
-12,233 Reduced 86.26%
1,948 $327,000
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $1.3 Million - $1.56 Million
9,014 Added 174.45%
14,181 $2.45 Million
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $639,157 - $807,602
5,167 New
5,167 $790,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.